expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense 11.26 10.75 (0.51) -4.57% 13.35 27.28 13.93 104.29% Income tax expense (1.31) 0.20 1.51 -115.10% (2.31) (1.74) 0.57 -24.64% Profit for the period 9.95 10.95 1.00 10.02% 11.05 25.54 14.49 131.20
ventures -51.84 -5.00 - - - - Financial cost -203.92 -125.43 62.58 -266.36 -147.43 80.67 Income taxed expense -70.65 -105.76 -33.20 -34.76 -84.45 -58.84 Loss for the period -22.67 125.01 -118.13 -151.79
bargain purchase 0.00 0.00 33.64 33.64 100.00 33.64 100.00 Profit before Selling and Administration expenses 12.61 58.17 81.06 22.89 39.35 68.45 543.05 Selling expense 3.36 26.92 8.54 -18.38 -68.27 5.18
113.09 Gain from bargain purchase 0.00 0.00 33.64 33.64 100.00 33.64 100.00 Profit before Selling and Administration expenses 12.61 58.17 81.06 22.89 39.35 68.45 543.05 Selling expense 3.36 26.92 8.54
(LOSS) BEFORE TAX (117.62) (16.23) 109.89 (24.43) (7.73) (40.66) INCOME TAX INCOME (EXPENSE) 1.97 (1.10) - - 1.97 (1.10) NET GAIN (LOSS) FOR THE YEARS (115.65) (17.33) 109.89 (24.43) (5.76) (41.76) Unit
57.70 -54.12 -206.61 63.42 28.86 119.75 Share of loss of associates and joint ventures -12.52 - - - - - Financial cost -53.82 -34.79 54.70 -71.89 -36.87 94.98 Income taxed expense -15.30 3.16 -584.18 2.08
20.91 EBIT 57.70 -54.12 -206.61 63.42 28.86 119.75 Share of loss of associates and joint ventures -12.52 - - - - - Financial cost -53.82 -34.79 54.70 -71.89 -36.87 94.98 Income taxed expense -15.30 3.16
% Financial expense (0.54) (0.61) (0.42) -22.22% -31.15% (1.76) (1.53) -13.07% Profit before income tax expense 70.74 14.15 40.93 -42.14% 189.26% 166.60 126.03 -24.35% Income tax expense (3.20) (0.24) 0.53